| UniProt-id | Site score | Size | D score | Volume | Exposure | Enclosure | Contact | Phobic | Philic | Balance | Don/Acc | Residues |
| P35228-1 | 1.077 | 349 | 1.042 | 1020.425 | 0.474 | 0.814 | 1.051 | 0.612 | 1.183 | 0.517 | 0.822 | 120,121,125,126,129,194,197,198,199,200,201,202,20 4,205,242,250,258,259,260,261,262,263,266,267,280, 282,283,284,285,286,305,346,347,350,352,354,355,36 9,370,371,372,373,374,376,377,380,381,382,385,387, 388,434,439,442,443,462,463,464,465,466,467,488,48 9,491,492,493,494,495,496
|
| P35228-2 | 1.062 | 131 | 1.079 | 577.612 | 0.502 | 0.783 | 1.046 | 0.832 | 1.014 | 0.82 | 0.672 | 705,711,712,713,887,888,889,890,943,944,945,946,97 6,977,978,983,985,1005,1007,1008,1014,1015,1016,10 17,1018,1044,1045,1047,1048,1051,1089,1096,1099,11 00
|
| UniProt accession | Gene name | DrugBank ID | Drug name | Drug group | Actions |
| P35228 | NOS2 | DB02644 | N-omega-propyl-L-arginine | experimental | |
| P35228 | NOS2 | DB02234 | S-Ethylisothiourea | experimental | |
| P35228 | NOS2 | DB14649 | Dexamethasone acetate | approved, investigational, vet_approved | negative modulator |
| P35228 | NOS2 | DB07388 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | experimental | |
| P35228 | NOS2 | DB05383 | Pimagedine | investigational | inhibitor, downregulator |
| P35228 | NOS2 | DB06879 | 5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE | experimental | |
| P35228 | NOS2 | DB05252 | Fenoxaprop-ethyl | investigational | |
| P35228 | NOS2 | DB03449 | N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide | experimental | |
| P35228 | NOS2 | DB08814 | Triflusal | approved, investigational | agonist |
| P35228 | NOS2 | DB03366 | Imidazole | experimental, investigational | |
| P35228 | NOS2 | DB06916 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE | experimental | |
| P35228 | NOS2 | DB07389 | N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE | experimental | |
| P35228 | NOS2 | DB02462 | Thiocoumarin | experimental | |
| P35228 | NOS2 | DB01234 | Dexamethasone | approved, investigational, vet_approved | negative modulator |
| P35228 | NOS2 | DB07003 | (2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | experimental | |
| P35228 | NOS2 | DB08214 | 4-(1H-IMIDAZOL-1-YL)PHENOL | experimental | |
| P35228 | NOS2 | DB04534 | 5-Nitroindazole | experimental | |
| P35228 | NOS2 | DB07029 | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE | experimental | |
| P35228 | NOS2 | DB09237 | Levamlodipine | approved, investigational | agonist |
| P35228 | NOS2 | DB07011 | (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE | experimental | |
| P35228 | NOS2 | DB11327 | Dipyrithione | approved | antagonist |
| P35228 | NOS2 | DB04400 | L-erythro-7,8-dihydrobiopterin | experimental | |
| P35228 | NOS2 | DB01017 | Minocycline | approved, investigational | inhibitor |
| P35228 | NOS2 | DB07008 | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE | experimental | |
| P35228 | NOS2 | DB07007 | (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | experimental | |
| P35228 | NOS2 | DB07318 | N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE | experimental | |
| P35228 | NOS2 | DB01686 | N,N-dimethylarginine | experimental | |
| P35228 | NOS2 | DB02207 | 7-Nitroindazole | experimental | |
| P35228 | NOS2 | DB00244 | Mesalazine | approved | inhibitor |
| P35228 | NOS2 | DB07002 | 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile | experimental | |
| P35228 | NOS2 | DB01381 | Ginkgo biloba | approved, investigational, nutraceutical | inhibitor |
| P35228 | NOS2 | DB00125 | Arginine | investigational, nutraceutical | |
| P35228 | NOS2 | DB01835 | 4R-Fluoro-N6-ethanimidoyl-L-lysine | experimental | |
| P35228 | NOS2 | DB00155 | Citrulline | investigational, nutraceutical | |
| P35228 | NOS2 | DB07306 | ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | experimental | |
| P35228 | NOS2 | DB07405 | 1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE | experimental | |
| P35228 | NOS2 | DB01997 | 3-Bromo-7-Nitroindazole | experimental | |
| P35228 | NOS2 | DB03953 | Thiocitrulline | experimental | |
| P35228 | NOS2 | DB05214 | KD7040 | investigational | |
| P35228 | NOS2 | DB03100 | 6-Nitroindazole | experimental | |
| P35228 | NOS2 | DB02044 | N-[3-(aminomethyl)benzyl]acetamidine | experimental | |
| P35228 | NOS2 | DB08750 | 1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE | experimental | |
| P35228 | NOS2 | DB03144 | N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine | experimental | |
| P35228 | NOS2 | DB01110 | Miconazole | approved, investigational, vet_approved | inhibitor |
| accession_id | uniprot_id | gene_name | Type | Variant | Clinical_significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1086Cys | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1086Cys | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1018Ser | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1018Ser | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ala782Val | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ala782Val | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Asn701Ser | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Asn701Ser | Likely benign |
| P35228 | P35228-1 | NOS2 | Duplication | p.Leu392fs | Uncertain significance |
| P35228 | P35228-1 | NOS2 | Duplication | p.Leu392fs | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Leu757Val | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Leu757Val | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Gly379Arg | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Gly379Arg | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Met355Ile | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Met355Ile | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro458Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro458Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Leu49Phe | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Leu49Phe | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.His1002Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.His1002Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Cys681Tyr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Cys681Tyr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Val415Ile | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Val415Ile | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg454Cys | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg454Cys | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Phe1132Tyr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Phe1132Tyr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro514Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro514Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Val943Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Val943Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1089Trp | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1089Trp | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Met656Thr | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Met656Thr | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Thr683Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Thr683Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser114Tyr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser114Tyr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Cys228Phe | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Cys228Phe | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ile265Val | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ile265Val | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Tyr1134His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Tyr1134His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Met1029Thr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Met1029Thr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Tyr1045Cys | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Tyr1045Cys | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg890Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg890Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg452Gln | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg452Gln | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser1066Arg | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser1066Arg | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ile227Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ile227Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Asn419Ser | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Asn419Ser | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Cys776Phe | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Cys776Phe | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ala168Val | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ala168Val | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro68Ser | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro68Ser | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser118Cys | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser118Cys | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Glu1031Ala | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Glu1031Ala | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro837Thr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro837Thr | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg232His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg232His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg530Gly | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg530Gly | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser425Gly | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser425Gly | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.His499Asp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.His499Asp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg278Gly | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg278Gly | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Thr63Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Thr63Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg750His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg750His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg452Trp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg452Trp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Glu402Ala | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Glu402Ala | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg914Gln | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg914Gln | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1006Trp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1006Trp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser114Phe | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser114Phe | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg740Trp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg740Trp | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Lys171Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Lys171Met | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Tyr336His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Tyr336His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro781Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Pro781Leu | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Lys952Arg | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Lys952Arg | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1047His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Arg1047His | Uncertain significance |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser608Leu | Benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Ser608Leu | Benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Thr182Met | Likely benign |
| P35228 | P35228-1 | NOS2 | single nucleotide variant | p.Thr182Met | Likely benign |